Cite
APA Citation
Scheithauer, W., Riera-Knorrenschild, J., Kopp, H., Mayer, F., Kroening, H., Nitsche, D., Kuhlmann, J., Ziebermayr, R., Andel, J., Arnold, D., Zurlo, A., Wittig, B., & Schmoll, H. (n.d.). 2089 Response to chemotherapy allows to identify mCRC patients most likely to benefit from maintenance immunotherapy: A post-hoc analysis from the IMPACT study. European journal of cancer, 51, S357–S358. http://access.bl.uk/ark:/81055/vdc_100030628203.0x00005c